July 17, 2018

Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical company, today announced the release of its latest product, Biolon OVD (ophthalmic viscosurgical device). Amring is excited to offer this new, cost-effective device and position itself in the growing ophthalmic market with the introduction of Biolon OVD.
Read more

Products Partner Company LinkedIn
More news & events